Nifty

:

23398.10

Sensex

:

74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Login

Nifty
Sensex

:
:

23398.10
74781.76

-79.70 (-0.34%)
-120.83 (-0.16%)

Eris Lifesciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

52/99

BSE: 540596 | NSE: ERIS

Watchlist

NSE BSE

1355.50

11-Sep-2026

Open
High
Low
Previous Close

1356.6
1362
1335.1
1356.60

Volume
Traded Value (lacs)
52 Week High
52 Week Low

24968
33774145.9
1740
1200

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

18,805.75
29.21
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

21,048.13
N/A
4.66

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.36
18.36
15.92

EBITDA CAGR (%)

10 Years
5 Years
3 Years

15.22
18.00
10.45

PAT CAGR (%)

10 Years
5 Years
3 Years

9.64
8.81
16.48

P:E (Median)

8 Years
5 Years
3 Years

27.86
30.92
44.91

P:BV (Average)

8 Years
5 Years
3 Years

5.71
5.55
6.03

EV:EBITDA (Average)

8 Years
5 Years
3 Years

20.10
20.32
21.65

Earnings Forecasts:

(Updated: 12-09-2026)

Description 2026 2027 2028 2029
Adj EPS 60 -1 30.19 36.11
P/E Ratio 22.59 -1355.50 44.90 37.54
Revenue 29.81 23.67 19.59 3215.37
EBITDA 3628.49 4120.59 4645.35 1148.66
Net Income 1322.23 1524.86 1731.77 495.08
ROA 667.76 840.46 1015.05 8.49
P/B Ratio 0.90 1.56 8.22 5.45
ROE 4.49 3.88 3.38 16.78
FCFF 15.91 17.3 17.78 -21.44
FCFF Yield -627.45 -611.2 132.96 -0.1
Net Debt -2.81 -2.73 0.59 1961.58
BVPS 1504.49 870.82 164.9 248.51

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 443.99 578.64 -23.27% 277.31 404.77 -31.49% 315.29 399.73 -21.12% 650.50 436.56 49.01%
Expenses 324.09 362.32 -10.55% 255.53 283.80 -9.96% 237.94 300.16 -20.73% 353.62 293.93 20.31%
EBITDA 119.90 216.32 -44.57% 21.78 120.97 -82.00% 77.35 99.57 -22.32% 296.88 142.63 108.15%
EBIDTM 27.01% 37.38% 7.85% 29.89% 24.53% 24.91% 45.64% 32.67%
Other Income 26.38 22.68 16.31% 26.97 16.75 61.01% 25.07 7.79 221.82% 23.59 5.81 306.02%
Interest 42.16 45.14 -6.60% 42.70 53.16 -19.68% 45.20 54.65 -17.29% 46.50 56.26 -17.35%
Depreciation 39.98 37.60 6.33% 38.82 43.38 -10.51% 38.66 46.68 -17.18% 39.30 46.16 -14.86%
PBT 64.14 156.26 -58.95% -32.77 41.18 - 3.89 6.03 -35.49% 234.67 46.02 409.93%
Tax 15.84 56.27 -71.85% -24.17 10.71 - 0.80 4.25 -81.18% 85.10 17.92 374.89%
PAT 48.30 99.99 -51.70% -8.60 30.47 - 3.09 1.78 73.60% 149.57 28.10 432.28%
PATM 10.88% 17.28% -3.10% 7.53% 0.98% 0.45% 22.99% 6.44%
EPS 3.48 7.21 -51.73% -0.62 2.20 - 0.22 0.13 69.23% 10.79 2.03 431.53%

Description Jun 26 Jun 25 Var% Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var%
Net Sales 873.25 773.00 12.97% 756.56 705.30 7.27% 807.45 727.45 11.00% 792.41 741.17 6.91%
Expenses 577.03 496.29 16.27% 482.99 452.91 6.64% 525.84 477.14 10.21% 504.20 476.66 5.78%
EBITDA 296.22 276.71 7.05% 273.57 252.39 8.39% 281.61 250.31 12.50% 288.21 264.51 8.96%
EBIDTM 33.92% 35.80% 36.16% 35.78% 34.88% 34.41% 36.37% 35.69%
Other Income 2.39 2.69 -11.15% 2.23 7.95 -71.95% 0.02 4.22 -99.53% 2.81 4.55 -38.24%
Interest 46.65 48.68 -4.17% 45.62 54.28 -15.95% 48.82 57.17 -14.61% 49.55 59.47 -16.68%
Depreciation 72.07 70.51 2.21% 69.57 77.25 -9.94% 70.34 81.00 -13.16% 69.08 80.38 -14.06%
PBT 179.89 160.21 12.28% 160.61 128.81 24.69% 145.23 116.36 24.81% 172.39 129.21 33.42%
Tax 36.17 36.00 0.47% -119.69 26.52 - 36.52 29.30 24.64% 38.20 32.80 16.46%
PAT 143.72 124.21 15.71% 280.30 102.29 174.02% 108.71 87.06 24.87% 134.19 96.41 39.19%
PATM 16.46% 16.07% 37.05% 14.50% 13.46% 11.97% 16.93% 13.01%
EPS 10.27 8.66 18.59% 20.33 6.89 195.07% 7.32 6.15 19.02% 8.82 6.73 31.05%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 1,687.09 1,821.74 1,697.75 1,486.71 1,330.72 1,215.73 1,108.83 1,020.23 896.54 760.60 712.90 Net Sales Growth -7.29% 7.30% 14.20% 11.72% 9.46% 9.64% 8.68% 13.80% 17.87% 6.69% Cost Of Goods Sold 605.99 626.70 499.25 280.16 236.38 199.65 198.51 164.35 132.35 115.94 135.66 Gross Profit 1,081.10 1,195.04 1,198.50 1,206.55 1,094.34 1,016.08 910.32 855.88 764.19 644.67 577.24 GP Margin 64.08% 65.60% 70.59% 81.16% 82.24% 83.58% 82.10% 83.89% 85.24% 84.76% 80.97% Total Expenditure 1,171.18 1,223.25 1,211.20 1,032.89 825.61 731.67 691.36 665.28 562.77 444.67 441.70 Power & Fuel Cost - 3.50 4.10 4.46 4.41 4.01 3.89 4.54 3.34 3.04 2.93 % Of Sales - 0.19% 0.24% 0.30% 0.33% 0.33% 0.35% 0.44% 0.37% 0.40% 0.41% Employee Cost - 340.62 361.92 331.67 252.52 220.11 207.02 191.73 166.77 130.84 116.31 % Of Sales - 18.70% 21.32% 22.31% 18.98% 18.11% 18.67% 18.79% 18.60% 17.20% 16.32% Manufacturing Exp. - 16.50 18.12 19.99 14.18 38.89 11.87 14.63 8.09 4.97 4.47 % Of Sales - 0.91% 1.07% 1.34% 1.07% 3.20% 1.07% 1.43% 0.90% 0.65% 0.63% General & Admin Exp. - 143.64 155.47 211.47 154.78 135.40 110.76 125.31 122.99 92.81 106.48 % Of Sales - 7.88% 9.16% 14.22% 11.63% 11.14% 9.99% 12.28% 13.72% 12.20% 14.94% Selling & Distn. Exp. - 58.56 144.75 140.07 137.77 98.34 109.88 131.07 125.15 95.36 72.99 % Of Sales - 3.21% 8.53% 9.42% 10.35% 8.09% 9.91% 12.85% 13.96% 12.54% 10.24% Miscellaneous Exp. - 33.73 27.59 45.07 25.57 35.28 49.43 33.64 4.09 1.71 72.99 % Of Sales - 1.85% 1.63% 3.03% 1.92% 2.90% 4.46% 3.30% 0.46% 0.22% 0.40% EBITDA 515.91 598.49 486.55 453.82 505.11 484.06 417.47 354.95 333.77 315.93 271.20 EBITDA Margin 30.58% 32.85% 28.66% 30.53% 37.96% 39.82% 37.65% 34.79% 37.23% 41.54% 38.04% Other Income 102.01 112.15 35.51 34.83 17.26 28.99 10.00 15.49 32.50 28.22 25.08 Interest 176.56 179.54 220.24 57.42 20.81 3.05 0.94 1.97 22.90 10.48 0.85 Depreciation 156.76 154.38 181.77 102.39 64.66 51.45 37.64 44.88 31.59 21.79 21.44 PBT 269.93 376.72 120.05 328.84 436.91 458.54 388.89 323.59 311.78 311.89 273.99 Tax 77.57 118.00 42.66 29.12 38.90 41.35 38.29 32.32 26.39 18.23 25.84 Tax Rate 28.74% 32.59% 35.54% 8.86% 8.90% 9.02% 9.85% 9.99% 8.46% 5.85% 9.43% PAT 192.36 244.05 77.39 299.72 398.01 417.19 350.61 291.27 285.38 293.65 248.14 PAT before Minority Interest 192.36 244.05 77.39 299.72 398.01 417.19 350.61 291.27 285.38 293.65 248.14 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 11.40% 13.40% 4.56% 20.16% 29.91% 34.32% 31.62% 28.55% 31.83% 38.61% 34.81% PAT Growth 19.97% 215.35% -74.18% -24.70% -4.60% 18.99% 20.37% 2.06% -2.82% 18.34% EPS 13.88 17.61 5.58 21.62 28.72 30.10 25.30 21.02 20.59 21.19 17.90

Description TTM Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Net Sales 3,229.67 3,129.42 2,893.64 2,009.15 1,685.15 1,347.04 1,211.86 1,074.06 982.16 855.60 749.50 Net Sales Growth 9.59% 8.15% 44.02% 19.23% 25.10% 11.15% 12.83% 9.36% 14.79% 14.16% Cost Of Goods Sold 850.21 795.60 713.99 380.05 352.35 258.51 238.27 171.53 153.70 141.57 133.60 Gross Profit 2,379.46 2,333.82 2,179.65 1,629.10 1,332.80 1,088.53 973.60 902.53 828.46 714.03 615.90 GP Margin 73.68% 74.58% 75.33% 81.08% 79.09% 80.81% 80.34% 84.03% 84.35% 83.45% 82.17% Total Expenditure 2,090.06 2,020.01 1,876.44 1,334.32 1,148.40 862.01 781.11 706.17 637.08 533.49 480.36 Power & Fuel Cost - 12.90 15.08 12.04 5.70 4.16 3.95 4.62 3.45 3.17 3.02 % Of Sales - 0.41% 0.52% 0.60% 0.34% 0.31% 0.33% 0.43% 0.35% 0.37% 0.40% Employee Cost - 556.81 505.09 403.82 346.16 250.18 229.30 205.69 190.66 157.32 131.22 % Of Sales - 17.79% 17.46% 20.10% 20.54% 18.57% 18.92% 19.15% 19.41% 18.39% 17.51% Manufacturing Exp. - 56.13 47.18 23.89 15.61 38.81 11.51 13.96 7.81 4.89 5.05 % Of Sales - 1.79% 1.63% 1.19% 0.93% 2.88% 0.95% 1.30% 0.80% 0.57% 0.67% General & Admin Exp. - 291.67 261.45 253.91 206.62 154.21 121.70 135.85 142.38 116.86 121.29 % Of Sales - 9.32% 9.04% 12.64% 12.26% 11.45% 10.04% 12.65% 14.50% 13.66% 16.18% Selling & Distn. Exp. - 253.51 289.47 208.45 185.16 121.39 128.70 140.99 134.82 107.67 84.32 % Of Sales - 8.10% 10.00% 10.38% 10.99% 9.01% 10.62% 13.13% 13.73% 12.58% 11.25% Miscellaneous Exp. - 53.39 44.18 52.16 36.80 34.74 47.69 33.53 4.25 2.00 84.32 % Of Sales - 1.71% 1.53% 2.60% 2.18% 2.58% 3.94% 3.12% 0.43% 0.23% 0.25% EBITDA 1,139.61 1,109.41 1,017.20 674.83 536.75 485.03 430.75 367.89 345.08 322.11 269.14 EBITDA Margin 35.29% 35.45% 35.15% 33.59% 31.85% 36.01% 35.54% 34.25% 35.13% 37.65% 35.91% Other Income 7.45 18.45 18.36 23.82 11.15 26.09 8.71 16.01 31.69 26.41 25.11 Interest 190.64 192.67 231.29 84.80 26.17 4.22 1.98 2.30 23.06 10.65 1.10 Depreciation 281.06 279.50 315.46 182.51 117.09 64.70 42.98 50.26 36.35 25.64 22.76 PBT 658.12 655.69 488.81 431.34 404.64 442.20 394.50 331.35 317.36 312.23 270.39 Tax -8.80 -8.97 114.20 34.22 30.48 36.41 39.36 34.84 26.21 17.25 23.78 Tax Rate -1.34% -1.40% 23.36% 7.93% 7.53% 8.23% 9.98% 10.51% 8.26% 5.52% 8.79% PAT 666.92 619.52 351.84 392.05 382.16 406.11 355.13 296.50 290.80 294.11 246.79 PAT before Minority Interest 645.11 647.51 374.67 397.12 374.16 405.79 355.13 296.51 291.15 294.98 246.61 Minority Interest -21.81 -27.99 -22.83 -5.07 8.00 0.32 0.00 -0.01 -0.35 -0.87 0.18 PAT Margin 20.65% 19.80% 12.16% 19.51% 22.68% 30.15% 29.30% 27.61% 29.61% 34.37% 32.93% PAT Growth 62.68% 76.08% -10.26% 2.59% -5.90% 14.36% 19.77% 1.96% -1.13% 19.17% EPS 48.12 44.70 25.39 28.29 27.57 29.30 25.62 21.39 20.98 21.22 17.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 3,195.46 2,514.90 2,524.02 2,221.88 1,918.56 1,575.47 1,299.70 1,156.01 868.18 574.60 Share Capital 13.85 13.62 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 Total Reserves 3,167.35 2,491.12 2,505.36 2,205.48 1,903.07 1,557.91 1,283.27 1,141.06 854.43 560.85 Non-Current Liabilities 638.39 1,430.23 259.97 4.22 -170.49 -161.81 -130.18 -114.05 196.33 -22.95 Secured Loans 797.62 1,632.64 485.94 209.47 0.00 0.00 0.00 0.00 273.69 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 46.93 57.98 40.56 31.03 28.84 29.14 24.13 16.47 15.02 19.80 Current Liabilities 1,723.39 1,010.95 2,322.55 361.73 249.79 212.42 203.06 360.46 277.88 114.26 Trade Payables 219.35 216.08 109.63 83.07 96.77 86.71 89.93 74.93 79.03 25.11 Other Current Liabilities 1,028.81 376.44 721.86 83.43 26.61 23.37 24.41 195.04 112.61 12.39 Short Term Borrowings 441.77 356.50 1,387.61 55.00 0.00 0.00 0.00 0.00 0.00 0.00 Short Term Provisions 33.46 61.93 103.45 140.22 126.41 102.34 88.72 90.50 86.24 76.76 Total Liabilities 5,557.24 4,956.08 5,106.54 2,587.83 1,997.86 1,626.08 1,372.58 1,402.42 1,342.39 665.91 Net Block 2,352.55 2,412.18 1,515.56 897.81 642.00 584.32 600.64 483.85 489.75 91.78 Gross Block 2,912.52 2,875.21 1,811.21 1,094.83 783.40 716.88 695.65 551.80 532.93 113.20 Accumulated Depreciation 559.97 463.03 295.65 197.01 141.40 132.55 95.01 67.96 43.19 21.43 Non Current Assets 4,528.77 4,311.53 3,169.24 1,957.80 1,334.30 1,134.47 869.37 782.82 958.53 399.30 Capital Work in Progress 0.00 0.27 0.61 0.34 2.98 1.55 4.37 2.73 0.00 0.00 Non Current Investment 1,414.05 991.27 1,618.95 966.51 678.18 480.97 246.03 274.36 451.84 290.43 Long Term Loans & Adv. 491.99 268.64 27.04 85.95 11.13 25.36 15.44 16.00 10.95 12.19 Other Non Current Assets 270.18 639.17 7.08 7.17 0.00 42.27 2.88 5.88 6.00 4.91 Current Assets 1,028.47 644.55 1,937.30 630.03 663.56 491.60 503.22 619.60 383.86 266.61 Current Investments 0.00 0.00 0.00 30.00 99.55 50.40 74.27 306.11 93.76 90.18 Inventories 121.36 191.25 91.63 63.70 84.79 64.85 65.46 74.70 57.52 47.20 Sundry Debtors 307.16 236.19 239.97 229.22 137.56 113.76 140.82 75.90 60.50 41.30 Cash & Bank 27.76 92.46 1,296.73 47.65 46.10 32.66 64.95 6.47 8.81 2.06 Other Current Assets 572.19 20.30 25.00 17.47 295.57 229.95 157.71 156.42 163.28 85.87 Short Term Loans & Adv. 549.61 104.35 283.97 241.99 274.60 204.25 109.46 103.14 123.50 82.40 Net Current Assets -694.92 -366.40 -385.25 268.30 413.77 279.18 300.16 259.13 105.98 152.35 Total Assets 5,557.24 4,956.08 5,106.54 2,587.83 1,997.86 1,626.07 1,372.59 1,402.42 1,342.39 665.91

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Shareholder's Funds 3,902.67 2,854.36 2,586.18 2,195.99 1,908.31 1,576.42 1,296.33 1,150.52 861.31 567.14 Share Capital 13.85 13.62 13.60 13.60 13.59 13.58 13.58 13.75 13.75 13.75 Total Reserves 3,874.56 2,830.65 2,567.56 2,179.59 1,892.82 1,558.87 1,279.90 1,135.57 847.56 553.39 Non-Current Liabilities 1,149.84 2,100.97 979.35 730.02 -78.80 -109.06 -79.63 -65.50 248.09 11.82 Secured Loans 955.83 1,737.51 654.51 644.45 45.00 0.00 0.00 0.29 274.19 0.49 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Provisions 86.78 78.97 52.72 44.67 32.16 31.47 25.98 19.39 18.71 22.96 Current Liabilities 2,201.22 1,492.79 2,608.96 521.18 283.34 235.45 220.17 377.25 293.98 129.27 Trade Payables 329.65 332.35 218.93 124.77 117.77 102.62 100.05 84.13 90.77 38.52 Other Current Liabilities 1,178.05 533.99 900.18 190.12 35.81 29.07 27.44 198.57 115.06 13.52 Short Term Borrowings 453.93 396.59 1,311.31 55.01 0.01 0.01 0.00 0.00 0.00 0.00 Short Term Provisions 239.59 229.86 178.54 151.29 129.75 103.76 92.68 94.55 88.15 77.24 Total Liabilities 7,246.72 6,865.52 6,810.40 3,471.88 2,112.74 1,702.81 1,436.87 1,480.58 1,428.04 732.02 Net Block 5,187.56 5,306.48 4,319.16 2,568.10 917.94 853.87 874.85 760.54 771.09 231.65 Gross Block 6,161.55 6,060.84 4,772.87 2,843.17 1,091.96 1,005.79 983.89 838.26 819.52 254.43 Accumulated Depreciation 973.99 754.36 453.71 275.07 174.02 151.92 109.04 77.73 48.42 22.78 Non Current Assets 5,582.75 5,531.13 4,431.47 2,629.21 1,401.72 1,167.24 901.78 827.09 1,060.81 462.52 Capital Work in Progress 171.47 67.01 19.67 21.72 26.99 1.55 4.37 2.73 0.00 0.07 Non Current Investment 61.56 62.00 15.55 6.69 420.84 243.65 3.20 40.91 271.61 213.05 Long Term Loans & Adv. 151.73 88.29 69.83 25.32 35.94 25.90 16.47 17.03 12.11 12.84 Other Non Current Assets 10.43 7.35 7.26 7.37 0.00 42.27 2.88 5.88 6.00 4.91 Current Assets 1,663.97 1,334.39 2,378.93 842.67 711.02 535.56 535.10 653.49 367.23 269.50 Current Investments 0.00 5.00 0.00 30.01 99.55 50.40 74.78 314.94 93.76 90.18 Inventories 436.82 334.83 189.03 131.44 117.91 94.47 69.47 82.65 65.45 55.82 Sundry Debtors 680.34 458.64 422.00 292.71 160.97 140.49 156.88 83.98 66.64 48.86 Cash & Bank 67.30 222.83 1,400.64 58.46 52.33 38.28 67.33 7.51 10.64 2.42 Other Current Assets 479.51 25.81 32.14 22.42 280.27 211.94 166.63 164.41 130.74 72.22 Short Term Loans & Adv. 435.47 287.28 335.12 307.65 256.23 175.70 111.48 106.85 86.48 68.48 Net Current Assets -537.25 -158.40 -230.03 321.49 427.68 300.12 314.93 276.24 73.25 140.22 Total Assets 7,246.72 6,865.52 6,810.40 3,471.88 2,112.74 1,702.80 1,436.88 1,480.58 1,428.04 732.02

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 563.94 701.86 336.29 322.33 369.41 395.41 265.25 216.31 236.28 209.72 PBT 362.05 120.05 328.83 436.91 458.54 388.89 323.59 311.78 311.89 273.99 Adjustment 263.17 393.56 144.12 73.70 31.04 36.11 39.36 24.57 7.63 -0.90 Changes in Working Capital 13.65 201.69 -63.18 -110.50 -37.26 38.44 -47.37 -50.18 -15.57 -11.17 Cash after chg. in Working capital 638.87 715.30 409.77 400.11 452.31 463.44 315.59 286.17 303.95 261.92 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -74.93 -13.44 -73.48 -77.79 -82.90 -68.03 -50.34 -69.86 -67.67 -52.21 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -694.16 -358.99 -2,491.89 -513.30 -267.64 -347.86 126.74 2.08 -592.73 -198.67 Net Fixed Assets -37.04 -1,063.66 -716.65 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 Net Investments -422.78 627.68 -622.44 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 Others -234.34 76.99 -1,152.80 14.27 46.67 -118.38 12.06 58.55 -8.01 -19.38 Cash from Financing Activity 71.06 -310.46 2,160.05 193.75 -88.42 -81.13 -333.52 -220.74 363.26 -17.52 Net Cash Inflow / Outflow -59.16 32.41 4.45 2.78 13.36 -33.58 58.47 -2.34 6.81 -6.48 Opening Cash & Equivalents 84.34 51.93 47.48 44.70 31.35 64.93 6.46 8.81 2.00 8.48 Closing Cash & Equivalent 25.18 84.34 51.93 47.48 44.70 31.35 64.93 6.46 8.81 2.00

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Cash From Operating Activity 537.99 1,065.01 486.01 291.74 378.26 375.36 271.17 223.00 234.63 200.21 PBT 638.54 488.87 431.34 404.64 442.20 394.50 331.35 317.36 312.23 270.39 Adjustment 481.86 548.05 254.16 139.84 49.25 44.07 44.24 30.50 14.12 -0.65 Changes in Working Capital -458.03 125.97 -98.74 -175.54 -29.90 5.33 -52.65 -53.24 -22.15 -16.45 Cash after chg. in Working capital 662.37 1,162.89 586.76 368.95 461.55 443.90 322.94 294.62 304.20 253.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -124.38 -97.88 -100.75 -77.21 -83.28 -68.53 -51.77 -71.63 -69.56 -53.08 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -369.46 -79.97 -1,854.52 -982.10 -319.61 -323.36 123.23 -5.05 -590.10 -184.46 Net Fixed Assets -37.04 -1,063.66 -716.65 -308.79 -67.95 -18.41 -145.49 -21.60 -419.73 -5.00 Net Investments -422.78 627.68 -622.44 -218.78 -246.36 -211.07 260.17 -34.87 -164.99 -174.29 Others 90.36 356.01 -515.43 -454.53 -5.30 -93.88 8.55 51.42 -5.38 -5.17 Cash from Financing Activity -313.53 -881.32 1,379.68 688.02 -44.70 -82.39 -334.59 -221.05 363.21 -23.66 Net Cash Inflow / Outflow -145.00 103.72 11.17 -2.34 13.96 -30.39 59.81 -3.11 7.75 -7.91 Opening Cash & Equivalents 199.74 94.25 56.02 50.87 36.91 67.31 7.50 10.61 2.34 8.87 Closing Cash & Equivalent 54.74 199.74 94.15 56.02 50.87 36.91 67.31 7.50 10.61 2.34

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 229.69 183.90 185.22 163.18 141.00 115.74 95.51 83.97 63.14 41.79 ROA 4.64% 1.54% 7.79% 17.36% 23.02% 23.38% 20.99% 20.79% 29.24% 46.70% ROE 8.58% 3.08% 12.65% 19.25% 23.92% 24.45% 23.76% 28.21% 40.71% 56.37% ROCE 10.83% 6.96% 10.18% 20.54% 26.42% 27.12% 24.74% 25.98% 35.45% 62.40% Fixed Asset Turnover 0.63 0.74 1.08 1.46 1.67 1.61 1.64 1.65 2.35 6.44 Receivable days 54.27 50.04 54.81 48.81 36.56 40.89 38.77 27.76 24.43 17.07 Inventory Days 31.22 29.73 18.15 19.76 21.77 20.93 25.07 26.92 25.13 24.74 Payable days 126.80 119.06 125.53 138.85 167.72 162.39 56.42 58.45 51.57 30.40 Cash Conversion Cycle -41.31 -39.30 -52.57 -70.28 -109.39 -100.57 7.42 -3.77 -2.02 11.41 Total Debt/Equity 0.65 0.88 1.00 0.14 0.00 0.00 0.00 0.15 0.43 0.00 Interest Cover 3.02 1.55 6.73 22.00 151.29 416.49 165.51 14.61 30.77 321.83

Description Mar 26 Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17
Book Value (Rs.) 280.75 208.83 189.79 161.28 140.25 115.81 95.26 83.58 62.64 41.25 ROA 9.18% 5.48% 7.72% 13.40% 21.27% 22.62% 20.33% 20.02% 27.31% 43.89% ROE 19.23% 13.81% 16.64% 18.25% 23.33% 24.78% 24.28% 28.96% 41.30% 56.90% ROCE 14.47% 13.59% 12.37% 17.30% 25.29% 27.60% 25.44% 26.54% 35.76% 62.56% Fixed Asset Turnover 0.53 0.55 0.56 0.90 1.33 1.25 1.18 1.18 1.59 3.97 Receivable days 63.88 54.06 61.68 46.91 39.44 43.59 40.93 27.99 24.64 18.07 Inventory Days 43.27 32.16 27.66 25.78 27.78 24.03 25.85 27.52 25.87 25.19 Payable days 151.85 140.91 165.04 125.63 155.58 155.23 59.47 59.07 54.07 32.17 Cash Conversion Cycle -44.70 -54.69 -75.70 -52.94 -88.36 -87.61 7.30 -3.57 -3.57 11.09 Total Debt/Equity 0.59 0.85 1.06 0.38 0.02 0.00 0.00 0.15 0.44 0.00 Interest Cover 4.31 3.11 6.09 16.46 105.81 200.75 145.25 14.76 30.31 246.14

Top Investors:

lilac investments limited

hdfc small cap fund

franklin india small cap fund

hetal rasiklal shah

bhikhalal chimanlal shah

naishadh vikram shah

uti-flexi cap fund

hsbc mutual fund - hsbc small cap fund

Annual Reports:

News Update:

Eris Lifesciences - Quarterly Results
30th Jul 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback